BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gallo M, Defaus S, Andreu D. Disrupting GPCR Complexes with Smart Drug-like Peptides. Pharmaceutics 2022;14:161. [PMID: 35057055 DOI: 10.3390/pharmaceutics14010161] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Ullrich J, Göhmann PJ, Zemella A, Kubick S. Oligomerization of the heteromeric γ-aminobutyric acid receptor GABA(B) in a eukaryotic cell-free system. Sci Rep 2022;12:20742. [PMID: 36456667 DOI: 10.1038/s41598-022-24885-0] [Reference Citation Analysis]
2 Cai X, Wang D, Zhang R, Chen Y, Chen J. The transmembrane domains of GPCR dimers as targets for drug development. Drug Discovery Today 2022. [DOI: 10.1016/j.drudis.2022.103419] [Reference Citation Analysis]
3 Aplin C, Milano SK, Zielinski KA, Pollack L, Cerione RA. Evolving Experimental Techniques for Structure-Based Drug Design. J Phys Chem B 2022. [PMID: 36029222 DOI: 10.1021/acs.jpcb.2c04344] [Reference Citation Analysis]
4 Casadó-Anguera V, Casadó V. Unmasking allosteric binding sites: Novel targets for GPCR drug discovery. Expert Opin Drug Discov 2022. [PMID: 35649692 DOI: 10.1080/17460441.2022.2085684] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]